Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On September 19, 2022, CytRx Corporation (the "Company") filed a Certificate of Amendment to Restated Certificate of Incorporation (the "Certificate of Amendment") to change the name of the Company from "CytRx Corporation" to "LadRx Corporation", effective as of September 26, 2022 (the "Name Change").

The Name Change does not affect the rights of the Company's security holders. The Company's securities will continue to be quoted on the OTC Markets under the ticker symbol "CYTR" until a change in the ticker symbol is effected. There will be no change to the Company's CUSIP in connection with the Name Change. Following the Name Change, the stock certificates, which reflect the former name of the Company, will continue to be valid. Certificates reflecting the Name Change will be issued in due course as old stock certificates are tendered for exchange or transfer to the Company's transfer agent.

Pursuant to Section 242 of the Delaware General Corporation Law, stockholder approval was not required to complete the Name Change or to approve or effect the Certificate of Amendment. The information set forth herein is qualified in its entirety by reference to the complete text of the Certificate of Amendment, a copy of which is filed with this report as Exhibit 3.1 and is incorporated by reference herein.

Item 7.01. Regulation FD Disclosure.

On September 23, 2022, the Company issued a press release announcing the Name Change. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated by reference herein.

The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished pursuant to Item 7.01 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description
3.1             Certificate of Amendment of Restated Certificate of Incorporation
              of the Company, as filed on September 19, 2022, with the Secretary
              of State of the State of Delaware
99.1            Press Release dated September 23, 2022 (furnished pursuant to Item
              7.01)
104           Cover Page Interactive Data File (formatted as Inline XBRL)

© Edgar Online, source Glimpses